2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 177.438 | 163.537 | 217.824 | 190.866 | 219.590 | 171.593 | 137.506 | 245.804 | 232.244 | 230.825 |
Total Income - EUR | 201.925 | 179.313 | 214.479 | 195.081 | 215.981 | 232.899 | 204.976 | 345.202 | 311.115 | 325.474 |
Total Expenses - EUR | 124.577 | 119.339 | 125.176 | 129.356 | 134.011 | 135.932 | 187.332 | 191.235 | 208.366 | 300.303 |
Gross Profit/Loss - EUR | 77.349 | 59.974 | 89.302 | 65.725 | 81.970 | 96.967 | 17.643 | 153.967 | 102.749 | 25.171 |
Net Profit/Loss - EUR | 66.207 | 50.153 | 75.014 | 62.882 | 80.252 | 95.000 | 16.319 | 151.018 | 99.909 | 22.621 |
Employees | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Vetgenes Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 34.070 | 46.048 | 89.200 | 82.572 | 260.739 | 256.768 | 273.707 | 382.195 | 494.018 | 713.482 |
Current Assets | 175.370 | 219.321 | 256.706 | 194.567 | 185.241 | 215.405 | 242.494 | 205.216 | 273.457 | 208.881 |
Inventories | 7.897 | 23.448 | 16.158 | 20.094 | 16.059 | 18.933 | 38.785 | 47.537 | 20.698 | 22.506 |
Receivables | 51.494 | 84.798 | 90.195 | 79.486 | 23.740 | 101.634 | 116.382 | 130.963 | 247.272 | 164.838 |
Cash | 25.642 | 16.640 | 6.851 | 6.809 | 19.061 | 28.940 | 87.327 | 26.716 | 5.487 | 21.537 |
Shareholders Funds | 167.392 | 218.942 | 176.002 | 204.777 | 281.272 | 370.824 | 380.113 | 490.358 | 591.788 | 612.614 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 42.048 | 46.428 | 169.904 | 72.362 | 164.708 | 101.348 | 136.088 | 97.053 | 175.687 | 309.749 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
111
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Vetgenes Srl